Abstract
The benzothiazepine derivative K-201 has been suggested as a potential therapeutic agent due to its antiarrhythmogenic action. To understand how the drug alters calcium release from the sarcoplasmic reticulum (SR), we investigated its effects on the SR calcium channel and calcium pump by single channel electrophysiology, whole-cell confocal microscopy, and ATPase activity measurements on control and post-myocardial infarcted (PMI) rat skeletal muscle. In bilayers, K-201 induced two subconductance states corresponding to ∼24% (S1) and ∼13% (S2) of the maximum conductance. Dependence of event frequency and of time spent in S1 and S2 on the drug concentration was biphasic both in control and in PMI rats, with a maximum at 50 μM. At this concentration, the channel spends 26 ± 4% and 24 ± 4%, respectively, of the total time in these subconductance states at positive potentials, while no subconductances are observed at negative potentials. K-201 altered the frequency of elementary calcium release events: spark frequency decreased from 0.039 ± 0.001 to 0.023 ± 0.001 s−1 sarcomere−1, while the frequency of embers increased from 0.011 ± 0.001 to 0.023 ± 0.001 s−1 sarcomere−1. Embers with different amplitude levels were observed after the addition of the drug. K-201 inhibited the Ca2+ ATPase characterized by IC50,contr = 119 ± 21 μM and n Hill,contr = 1.84 ± 0.48 for control and IC50,PMI = 122 ± 18 μM and n Hill,PMI = 1.97 ± 0.24 for PMI animals. These results suggest that although K-201 would increase the appearance of subconductance states, the overall calcium release is reduced by the drug. In addition, the effect of K-201 is identical on calcium release channels from control and PMI rats.
Similar content being viewed by others
References
Altafaj X, France J, Almassy J, Jona I, Rossi D, Sorrentino V, Mabrouk K, De Waard M, Ronjat M (2007) Maurocalcine interacts with cardiac ryanodine receptor without inducing channel modification. Biochem J 406:309–315
Aronow WS (2006) Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure. Cardiol Rev 14:108–124
Boyden PA, Dun W, Barbhaiya C, Ter Keurs HE (2004) 2APB- and JTV519(K201)-sensitive micro Ca2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart. Heart Rhythm 1:18–26
Fabiato A (1988) Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol 157:378–417
Gómez AM, Schuster I, Fauconnier J, Prestle J, Hasenfuss G, Richard S (2004) FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+] transient in rat cardiac myocytes. Am J Phys 287:H1987–H1993
Hunt DJ, Jones PP, Wang R, Chen W, Bolstad J, Chen K, Shimoni Y, Chen SR (2007) K201(JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. Biochem J 404:431–438
Inagaki K, Kihara Y, Izumi T, Sasayama S (2000) The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts. Cardiovasc Drugs Ther 14:489–495
Jona I, Szegedi C, Sarkozi S, Szentesi P, Csernoch L, Kovacs L (2001) Altered inhibition of the rat skeletal ryanodine receptor/calcium release channel by magnesium in the presence of ATP. Pflügers Arch - Eur J Physiol 441:729–738
Kaneko N (1994) New 1,4-Benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res 33:429–438
Kaneko N, Ago H, Matsuda R, Inagaki E, Miyano M (1997a) Chrystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor. J Mol Biol 274:16–20
Kaneko N, Matsuda R, Toda M, Shimamoto K (1997b) Inhibition of annexin V-dependent Ca2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. Biochim Biophys Acta 1330:1–7
Kawabata H, Ryomoto T, Ishikawa K (2000) Effect of a novel cardioprotective agent, JTV-519, on metabolism, contraction and relaxation in the ischemia-reperfused rabbit heart. Jpn Circ J 64:772–776
Kawabata H, Nakawaga K, Ishikawa K (2002) A novel cardioprotective agent, JTV-519, is abolished by nitric oxide synthase inhibitor on myocardial metabolism in ischemia-reperfused rabbit hearts. Hypertens Res 25:303–309
Kirsch WG, Uttenweiler D, Fink RH (2001) Spark- and ember-like elementary Ca2+ release events in skinned fibres of adult mammalian skeletal muscle. J Physiol 537:379–389
Kohno M, Yano M, Kobayashi S, Doi M, Oda T, Tokuhisa T, Okuda S, Ohkusa T, Kohno M, Matsuzaki M (2003) A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. Am J Physiol Heart Circ Physiol 284:H1035–H1042
Kumagai K, Nakashima H, Gondo N, Saku K (2003) Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. J Cardiovasc Electrophysiol 14:880–884
Lai FA, Meissner G (1990) Structure of the calcium release channel of skeletal muscle sarcoplasmic reticulum and its regulation by calcium. Adv Exp Med Biol 269:73–77
Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR (2004) Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109:3208–3214
Lehnart SE, Terrenoire C, Reiken SR, Wehrens XH, Song LS, Song LS, Tillman EJ, Mancarella S, Coromilas J, Lederer WJ, Kass RS, Marks AR (2006) Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. PNAS 103:7906–7910
Lehnart SE (2007) Novel targets for treating heart and muscle disease-stabilizing ryanodine receptors and preventing intracellular calcium leak. Curr Opin Pharmacol 7:225–232
Lisy O, Burnett JC Jr (2006) New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing. Circulation 113:246–251
Pitt GS, Dun W, Boyden PA (2006) Remodelled cardiac calcium channels. J Moll Cell Cardiol 43:373–388
Sarkozi S, Szentesi P, Jona I, Csernoch L (1996) Effects of cardiac glycosides on excitation-contraction coupling in frog skeletal muscle fibres. J Physiol 495:611–626
Shirokova N, Garcia J, Rios E (1998) Local calcium release in mammalian skeletal muscle. J Physiol 512:377–384
Szappanos H, Smida-Rezgui S, Cseri J, Simut C, Sabatier JM, De Waard M, Kovacs L, Csernoch L, Ronjat M (2005) Differential effects of maurocalcine on Ca2+ release events and depolarization-induced Ca2+ release in rat skeletal muscle. J Physiol 565:843–853
Szentesi P, Jacquemond V, Kovacs L, Csernoch L (1997) Intramembrane charge movement and sarcoplasmic calcium release in enzymatically isolated mammalian skeletal muscle fibers. J Physiol 505:371–384
Szentesi P, Szappanos H, Szegedi C, Gonczi M, Jona I, Cseri J, Kovacs L, Csernoch L (2004) Altered elementary calcium release events and enhanced calcium release by thymol in rat skeletal muscle. Biophys J 86:1436–1453
Szigeti GP, Almassy J, Sztretye M, Dienes B, Szabo L, Szentesi P, Vassort G, Sarkozi S, Csernoch L, Jona I (2007) Alterations in the calcium homeostasis of skeletal muscle from postmyocardial infarcted rats. Pflugers Arch 455:541–553
Ward CW, Reiken S, Marks AR, Marty I, Vassort G, Lacampagne A (2003) Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats. FASEB J 17:1517–1519
Werhens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR (2004) Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304:292–296
Wehrens XH, Lehnart SE, Reiken SR, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR (2005) Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. PNAS 102:9607–9612
Yano M, Kobayasi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Okhusa T, Kohno M, Matsuzaki M (2003) FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107:477–484
Zhou J, Brum G, Gonzalez A, Launikonis BS, Stern MD, Rios E (2003) Ca2+ sparks and embers of mammalian muscles. Properties of the sources. J Gen Physiol 122:195–114
Acknowledgements
The authors are grateful for the technical assistance of Ms R. Őri and Ms. É. Sági. The work was supported by grants from the Hungarian Scientific Research Fund OTKA (T049151, T61442, NK61412) and by INSERM.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Almassy, J., Sztretye, M., Lukacs, B. et al. Effects of K-201 on the calcium pump and calcium release channel of rat skeletal muscle. Pflugers Arch - Eur J Physiol 457, 171–183 (2008). https://doi.org/10.1007/s00424-008-0504-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-008-0504-7